Rocket Pharmaceuticals (RCKT) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

RCKT Rocket Pharmaceuticals

Watchlist

17.310
-0.270-1.54%

Trading Nov 7 15:38 ET

1.57BMarket Cap-6249P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

KBRA Assigns Preliminary Ratings to RCKT Mortgage Trust 2024-CES8 (RCKT 2024-CES8)
BusinesswireOct 16 11:09 ET
Rocket Pharmaceuticals Initiated With an Outperform at Scotiabank
TipRanksOct 16 07:45 ET · Ratings
We're Keeping An Eye On Rocket Pharmaceuticals' (NASDAQ:RCKT) Cash Burn Rate
Simply Wall StOct 3 09:36 ET
Rocket Pharmaceuticals Is Maintained at Buy by Canaccord Genuity
Dow JonesSep 30 11:40 ET · Ratings
CCORF Maintains Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Maintains Target Price $38
Moomoo NewsSep 25 08:31 ET · Ratings
A Quick Look at Today's Ratings for Rocket Pharmaceuticals(RCKT.US), With a Forecast Between $38 to $53
Moomoo NewsSep 18 09:00 ET · Ratings

Comments

$Rocket Pharmaceuticals (RCKT.US)$ 25 next

This could be bad today? NFA

$Rocket Pharmaceuticals (RCKT.US)$ Benzinga· 4 mins ago
The FDA Issued Complete Response Letter To Rocket Pharmaceuticals' Kresladi (Marnetegragene Autotemcel), Gene Therapy For Severe Leukocyte Adhesion Deficiency-i, The FDA Requested Limited Additional CMC Information

👀 Keep an eye out for the remaining PDUFAs in June! 🔥

$Sarepta Therapeutics (SRPT.US)$ : ELEVIDYS
$Harmony Biosciences (HRMY.US)$ : WAKIX (pitolisant)
$Bristol-Myers Squibb (BMY.US)$ : KRAZATI (Adagrasib) + Cetuximab
$argenx SE (ARGX.US)$ : VYVGART Hytrulo (Efgartigimod)
$Merck & Co (MRK.US)$ : Patritumab deruxtecan
$Verona Pharma (VRNA.US)$ : Ensifentrine (Nebulized)
$Rocket Pharmaceuticals (RCKT.US)$ : KRESLADI (Marnetegragene autotemcel)

👀 Keep an eye out for the remaining PDUFAs in June! 🔥

14

🚨 June PDUFAs

» 15+ upcoming FDA decisions to watch: 👀 👇
$GlaxoSmithKline (GSK.US)$ : Arexvy
$Genfit (GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD (IPSEY.US)$ : Elafibranor
$Eli Lilly and Co (LLY.US)$ : Donanemab - AdCom meeting 🗓️
$Regeneron Pharmaceuticals (REGN.US)$ : Kevzara (sarilumab)
$Bristol-Myers Squibb (BMY.US)$ : Augtyro™ (Repotrectinib)
$Geron (GERN.US)$ : Imetelstat
$Merck & Co (MRK.US)$ : V116
$Amgen (AMGN.US)$ : BLINCYTO (blinatumomab)
$Sarepta Therapeutics (SRPT.US)$ : ELEVIDYS
$Merck & Co (MRK.US)$ : KEYTRUDA ...

🚨 June PDUFAs

16

See remaining FDA PDUFAs in May 👀👇
$Bristol-Myers Squibb (BMY.US)$ : Breyanzi
‣ PDUFA date: 5/31/24 (sBLA)
$Moderna (MRNA.US)$ : mRNA-1345
‣ PDUFA date: End of May 2024 (est.) (BLA)
📣 Buckle up & get ready for next month...
June brings 17 PDUFA decisions: 🔥 🔥
$Catalyst Pharmaceuticals (CPRX.US)$ : FIRDAPSE® (Amifampridine)
$GlaxoSmithKline (GSK.US)$ : Arexvy
$Genfit (GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD (IPSEY.US)$ : Elafibranor
$Regeneron Pharmaceuticals (REGN.US)$ : Kevzara (sarilumab)
$Bristol-Myers Squibb (BMY.US)$ : Augtyro...

8

1

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data